CHICAGO, Feb 15 (Reuters) - Bristol-Myers Squibb (BMY.N: Quote, Profile, Research) on Wednesday said it cut a deal with two generic drugmakers to allow cheap versions of its newest AIDS drug to be made in sub-Saharan Africa and India, where millions suffer from the disease.
